60 results about "CHITOSAN PCA" patented technology

One method for purifying a chitosan starting material includes contacting it with at least one treatment agent selected from a protein-complexing agent, a metal-chelating agent, and a metal-complexing agent under pH conditions effective for forming a water insoluble chitosan precipitate and at least one water soluble material selected from a water soluble protein complex, a water soluble metal chelate, and a water soluble metal complex. Another variant involves solubilizing the chitosan starting material in an aqueous solution to produce an intermediate chitosan material. The intermediate chitosan material is contacted with a deproteinization agent and / or a demetallization agent under pH conditions effective for forming a water insoluble chitosan precipitate and at least one water soluble material that includes the pre-existing impurity. In both methods, the water insoluble chitosan precipitate and the water soluble material are separated resulting in a purified chitosan material.

Compositions, methods and kits for purifying and clarifying and / or nutrifying contaminated drinking water and which comprise a primary coagulant material and a bridging flocculent material, the levels and ratios of coagulant to flocculent preferably falling within certain ranges. Highly preferred compositions also contain one or more of a cationic coagulant aid, especially chitosan, a microbiocidal disinfectant, a water-soluble alkali, a water-insoluble silicate, and a food additive or nutrient source.

The present invention pertains to chitosan beads consisting of chitosan cross-linked with citrate ions. The present invention furthermore pertains to a filler comprising such chitosan-citrate beads. In one embodiment of the instant invention the filler is a dermal filler. In one further embodiment of the present invention the dermal filler is for the treatment of wrinkles and / or folds. In another embodiment of the instant invention the filler is for use in the treatment of a medical condition. The filler provided in the present invention may further comprise one or more active pharmaceutical ingredients. Further, the present invention pertains to a process for preparing the filler as claimed herein.

The present invention herein provides a chitosan-containing polysaccharide and a method for the preparation thereof as well as a medicine and a food containing the polysaccharide. The chitosan-containing polysaccharide is prepared by a method comprising the steps of heat-treating a fungus in a concentrated aqueous caustic alkali solution; subjecting the resulting solution to a solid-liquid separation treatment; dissolving the resulting solid contents in an aqueous organic acid solution; adding, to the resulting solution, an alcohol or a caustic alkali to thus form precipitates; washing the resulting precipitates; and then drying them. This chitosan-containing polysaccharide is a compound in which homopolymers of glucosamine are linked with glucan through covalent bonds; it has a molar ratio of glucosamine and glucose constituting the polysaccharide ranging from 1:5 to 5:1; it has a molecular weight of about 150,000; and it does not contain any beta (1->3) bonds, but comprises beta (1->4) bonds and beta (1->6) bonds. The polysaccharide is free of any protein and reducing polysaccharide. The chitosan-containing polysaccharide is effective for the treatment or prevention of any diseases originated from living habits or customs such as hypertension and diabetes.

Compositions and methods of producing paper-based materials are disclosed. In general, the techniques utilize an amine-containing polymer, such as chitosan, to functionalize one or more components of a mixture used to form materials such as paper-based materials. Such components can include the fibers of a pulp and / or filler particles. In one instance, either the pulp or the filler particles are functionalized, but not both. Such functionalization can improve the qualifies of a paper-based material relative to when such functionalization is not utilized. Techniques and compositions are also described to further improve the qualities of a paper material by utilizing a complementary polymer which can couple with the amine-containing polymer.

The present invention relates to dehydrated nanoparticles comprising chitosan and a nucleic acid. Preferably, the nucleic acid is a siRNA. Dehydrated nanoparticles of the invention have improved storage characteristics. The particles may be used in screening methods, e.g. where they have been dried onto a solid support, such as the surface of a culture well. The nanoparticles may also be dried onto implants for tissue engineering scaffolds, where they enable transfection of cells growing on the scaffold. Moreover, the particles have therapeutic relevance.

The invention discloses a compound composition containing salicylic acid and chitosan, wherein the weight ratio of salicylic acid to chitosan is 1:1-1:1.8, and pH of the composition is 2.0-5.0. The invention further relates to a preparation method of the composition containing salicylic acid and chitosan, and application of the composition in cosmetics.

A system and method is disclosed for pre-treating water to remove substantial amounts of particulates prior to filtration. A coagulant, such as chitosan is mixed with turbid water and adheres to particulate matter to form large clumps. The water / coagulant mixture is placed in a first reservoir elevated above a second reservoir having a strip of porous material, such as polyester felt, positioned with one end in the first reservoir and another end above the second reservoir and preferably below the waterline in the first reservoir. A middle portion of the porous material is elevated above the first and second ends, but at a height relative to the waterline of the first reservoir that is equal or less than the height water will rise in the porous material due to capillary action.

A composition and a method of applying the composition to a site on or within a body of a mammal. The composition includes a hydrogel matrix that includes at least one polymer cross linked, via ionic or covalent bonding, with both hyaluronic acid and alginic acid. The at least one polymer is chitosan, poly L-Lysine, or a combination thereof.

The invention provides a composition for increasing skin glossiness and / or improving skin brightness and / or increasing skin whiteness. The composition comprises 0.01 to 6 wt% of lactobionic acid, 0.01 to 6 wt% of chitosan, and a cosmetically acceptable carrier. The invention also relates to an application of the composition in a skin external preparation and a method for increasing skin glossiness and / or improving skin brightness and / or increasing skin whiteness.